Other Species / Isoforms
  CK1G2 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R25
MSKTGTSRSNHGVRS
0 1
CK1G2 (human) MSKAGGGrsSHGIRS R25-m1
CK1G2 (mouse) MSKTGTSRSNHGVRS R25
S26
SKTGTSRSNHGVRSS
0 1
CK1G2 (human) SKAGGGrsSHGIRSs S26-p
CK1G2 (mouse) SKTGTSRSNHGVRSS S26
S33
SNHGVRSSGTSSGVL
0 4
CK1G2 (human) sSHGIRSsGtsSGVL S33-p
CK1G2 (mouse) SNHGVRSSGTSSGVL S33
T35
HGVRSSGTSSGVLMV
0 2
CK1G2 (human) HGIRSsGtsSGVLMV T35-p
CK1G2 (mouse) HGVRSSGTSSGVLMV T35
S36
GVRSSGTSSGVLMVG
0 1
CK1G2 (human) GIRSsGtsSGVLMVG S36-p
CK1G2 (mouse) GVRSSGTSSGVLMVG S36
Y67
LRLGKNLYTNEYVAI
0 1
CK1G2 (human) LRLGKNLyTNEyVAI Y67-p
CK1G2 (mouse) LRLGKNLYTNEYVAI Y67
Y71
KNLYTNEYVAIKLEP
0 8
CK1G2 (human) KNLyTNEyVAIKLEP Y71-p
CK1G2 (mouse) KNLYTNEYVAIKLEP Y71
Y90-p
APQLHLEyRFYKQLS
0 2
CK1G2 (human) APQLHLEyRFYKQLS Y90-p
CK1G2 (mouse) APQLHLEyRFYKQLS Y90-p
T138
DLCDRTFTLKTVLMI
0 1
CK1G2 (human) DLCDRTFtLKtVLMI T138-p
CK1G2 (mouse) DLCDRTFTLKTVLMI T138
T141
DRTFTLKTVLMIAIQ
0 1
CK1G2 (human) DRTFtLKtVLMIAIQ T141-p
CK1G2 (mouse) DRTFTLKTVLMIAIQ T141
T151
MIAIQLITRMEYVHT
0 1
CK1G2 (human) MIAIQLItRMEYVHt T151-p
CK1G2 (mouse) MIAIQLITRMEYVHT T151
T158
TRMEYVHTKSLIYRD
0 1
CK1G2 (human) tRMEYVHtKSLIYRD T158-p
CK1G2 (mouse) TRMEYVHTKSLIYRD T158
K167
SLIYRDVKPENFLVG
0 1
CK1G2 (human) SLIYRDVkPENFLVG K167-ub
CK1G2 (mouse) SLIYRDVKPENFLVG K167
Y195
DFGLAKEYIDPETKK
0 1
CK1G2 (human) DFGLAKEyIDPETKK Y195-p
CK1G2 (mouse) DFGLAKEYIDPETKK Y195
S211-p
IPYREHKsLTGtARY
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Putative in vivo kinases:
  • CK1G2 (mouse)
CK1G2 (human) IPYREHKSLTGTARY S211
CK1G2 (mouse) IPYREHKsLTGtARY S211-p
T215-p
EHKsLTGtARYMSIN
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Putative in vivo kinases:
  • CK1G2 (mouse)
CK1G2 (human) EHKSLTGTARYMSIN T215
CK1G2 (mouse) EHKsLTGtARYMSIN T215-p
K256-ub
SLPWQGLkADTLKER
0 8
CK1G2 (human) SLPWQGLkADTLKER K256-ub
CK1G2 (mouse) SLPWQGLkADTLKER K256-ub
T336
WAGKPLPTPIGTVHP
0 1
CK1G2 (human) WAGKPLPtPIGTVHT T336-p
CK1G2 (mouse) WAGKPLPTPIGTVHP T336
S347-p
TVHPDVPsQPPHRDK
Upstream
0 1
Treatment
  • insulin
CK1G2 (human) TVHTDLPSQPQLRDK S347
CK1G2 (mouse) TVHPDVPsQPPHRDK S347-p
T359
RDKAQLHTKNQALNS
0 1
CK1G2 (human) RDKTQPHsKNQALNs S359-p
CK1G2 (mouse) RDKAQLHTKNQALNS T359
S366
TKNQALNSTNGELNT
0 2
CK1G2 (human) sKNQALNstNGELNA S366-p
CK1G2 (mouse) TKNQALNSTNGELNT S366
T367
KNQALNSTNGELNTD
0 2
CK1G2 (human) KNQALNstNGELNAD T367-p
CK1G2 (mouse) KNQALNSTNGELNTD T367
T377
ELNTDDPTAGHSNAP
0 1
CK1G2 (human) ELNADDPtAGHsNAP T377-p
CK1G2 (mouse) ELNTDDPTAGHSNAP T377
S381
DDPTAGHSNAPIAAP
0 2
CK1G2 (human) DDPtAGHsNAPITAP S381-p
CK1G2 (mouse) DDPTAGHSNAPIAAP S381
S410
FKRRKRKSLQRHK__
0 8
CK1G2 (human) FKRRKRKsLQRHK__ S410-p
CK1G2 (mouse) FKRRKRKSLQRHK__ S410